Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Paracetamol and phenyltoloxamine and salicylamide only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Product containing only paracetamol and phenyltoloxamine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing only isometheptene and paracetamol in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing only dihydrocodeine and paracetamol in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing only paracetamol and pseudoephedrine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing only paracetamol and salicylamide in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Paracetamol and sodium salicylate only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing only paracetamol and tramadol in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing only paracetamol in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Paracetamol only product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only paracetamol in rectal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only aspirin and caffeine and paracetamol in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Product containing only metoclopramide and paracetamol in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Diphenhydramine and paracetamol only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Paracetamol allergy |
Causative agent (attribute) |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Hydrocodone and paracetamol only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Butalbital and caffeine and codeine and paracetamol only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Dextropropoxyphene and paracetamol only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing only butalbital and caffeine and paracetamol in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Butalbital and paracetamol only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Oxycodone and paracetamol only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only codeine and paracetamol in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely paracetamol 10 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Has precise active ingredient |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely paracetamol 10 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Has basis of strength substance (attribute) |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Allergy to acetaminophen and dextropropoxyphene |
Causative agent (attribute) |
False |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely dextropropoxyphene hydrochloride 32.5 milligram and paracetamol 325 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely dextropropoxyphene hydrochloride 32.5 milligram and paracetamol 325 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely metoclopramide hydrochloride 5 milligram and paracetamol 500 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely metoclopramide hydrochloride 5 milligram and paracetamol 500 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Paracetamol 80 mg chewable tablet |
Has basis of strength substance (attribute) |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Paracetamol 80 mg chewable tablet |
Has precise active ingredient |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Paracetamol 160 mg chewable tablet |
Has precise active ingredient |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Paracetamol 160 mg chewable tablet |
Has basis of strength substance (attribute) |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Paracetamol 250 mg orodispersible tablet |
Has precise active ingredient |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Paracetamol 250 mg orodispersible tablet |
Has basis of strength substance (attribute) |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely caffeine 100 milligram and isometheptene mucate 65 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug) |
Has precise active ingredient |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Product containing precisely caffeine 100 milligram and isometheptene mucate 65 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug) |
Has basis of strength substance (attribute) |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Product containing precisely codeine phosphate 8 milligram and paracetamol 500 milligram/1 each conventional release effervescent oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely codeine phosphate 8 milligram and paracetamol 500 milligram/1 each conventional release effervescent oral tablet (clinical drug) |
Has precise active ingredient |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Acetaminophen 80mg pessary |
Has basis of strength substance (attribute) |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Acetaminophen 80mg pessary |
Has precise active ingredient |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Paracetamol 300 mg rectal suppository |
Has basis of strength substance (attribute) |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Paracetamol 300 mg rectal suppository |
Has precise active ingredient |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Paracetamol 325 mg rectal suppository |
Has precise active ingredient |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Paracetamol 325 mg rectal suppository |
Has basis of strength substance (attribute) |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely paracetamol 500 milligram/1 each conventional release effervescent oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely paracetamol 500 milligram/1 each conventional release effervescent oral tablet (clinical drug) |
Has precise active ingredient |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely paracetamol 650 milligram/1 each conventional release rectal suppository (clinical drug) |
Has precise active ingredient |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely paracetamol 650 milligram/1 each conventional release rectal suppository (clinical drug) |
Has basis of strength substance (attribute) |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely paracetamol 48.2 milligram/1 milliliter conventional release oral solution (clinical drug) |
Has basis of strength substance (attribute) |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely paracetamol 48.2 milligram/1 milliliter conventional release oral solution (clinical drug) |
Has precise active ingredient |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely paracetamol 120 milligram/1 milliliter conventional release oral solution (clinical drug) |
Has basis of strength substance (attribute) |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely paracetamol 120 milligram/1 milliliter conventional release oral solution (clinical drug) |
Has precise active ingredient |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely hydrocodone bitartrate 500 microgram/1 milliliter and paracetamol 21.7 milligram/1 milliliter conventional release oral solution (clinical drug) |
Has basis of strength substance (attribute) |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely hydrocodone bitartrate 500 microgram/1 milliliter and paracetamol 21.7 milligram/1 milliliter conventional release oral solution (clinical drug) |
Has precise active ingredient |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Paracetamol 32 mg/mL oral solution |
Has precise active ingredient |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Paracetamol 32 mg/mL oral solution |
Has basis of strength substance (attribute) |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely paracetamol 16 milligram/1 milliliter conventional release oral solution (clinical drug) |
Has basis of strength substance (attribute) |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely paracetamol 16 milligram/1 milliliter conventional release oral solution (clinical drug) |
Has precise active ingredient |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing paracetamol and promethazine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing paracetamol and pentazocine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Paracetamol- and promethazine-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Paracetamol and promethazine only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Paracetamol- and pentazocine-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely diphenhydramine hydrochloride 25 milligram and paracetamol 500 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely diphenhydramine hydrochloride 25 milligram and paracetamol 500 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely paracetamol 24 milligram/1 milliliter and promethazine hydrochloride 300 microgram/1 milliliter conventional release oral suspension (clinical drug) |
Has precise active ingredient |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely paracetamol 24 milligram/1 milliliter and promethazine hydrochloride 300 microgram/1 milliliter conventional release oral suspension (clinical drug) |
Has basis of strength substance (attribute) |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Paracetamol 650 mg and pentazocine 25 mg oral tablet |
Has precise active ingredient |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Paracetamol 650 mg and pentazocine 25 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely codeine phosphate 8 milligram and paracetamol 500 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely codeine phosphate 8 milligram and paracetamol 500 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing only paracetamol and pentazocine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing only paracetamol and pentazocine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Paracetamol and promethazine only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Chlorphenamine- and paracetamol- and phenylephrine-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Product containing only chlorphenamine and paracetamol and phenylephrine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Product containing precisely codeine phosphate 8 milligram and paracetamol 500 milligram/1 each conventional release oral capsule (clinical drug) |
Has precise active ingredient |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely codeine phosphate 8 milligram and paracetamol 500 milligram/1 each conventional release oral capsule (clinical drug) |
Has basis of strength substance (attribute) |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely hydrocodone bitartrate 333 microgram/1 milliliter and paracetamol 33.3 milligram/1 milliliter conventional release oral solution (clinical drug) |
Has precise active ingredient |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely hydrocodone bitartrate 333 microgram/1 milliliter and paracetamol 33.3 milligram/1 milliliter conventional release oral solution (clinical drug) |
Has basis of strength substance (attribute) |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely caffeine 650 microgram/1 milliliter and paracetamol 5 milligram/1 milliliter conventional release oral solution (clinical drug) |
Has precise active ingredient |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely caffeine 650 microgram/1 milliliter and paracetamol 5 milligram/1 milliliter conventional release oral solution (clinical drug) |
Has basis of strength substance (attribute) |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Paracetamol-containing product in oromucosal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Paracetamol only product in oromucosal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing caffeine and isometheptene and paracetamol in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Product containing only caffeine and isometheptene and paracetamol in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Product containing precisely hydrocodone bitartrate 500 microgram/1 milliliter and paracetamol 33.3 milligram/1 milliliter conventional release oral solution (clinical drug) |
Has precise active ingredient |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely hydrocodone bitartrate 500 microgram/1 milliliter and paracetamol 33.3 milligram/1 milliliter conventional release oral solution (clinical drug) |
Has basis of strength substance (attribute) |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely paracetamol 500 milligram/1 each tablet for conventional release oral solution (clinical drug) |
Has basis of strength substance (attribute) |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely paracetamol 500 milligram/1 each tablet for conventional release oral solution (clinical drug) |
Has precise active ingredient |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Methionine 100 mg and paracetamol 500 mg oral tablet |
Has precise active ingredient |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Methionine 100 mg and paracetamol 500 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Dihydrocodeine tartrate 10 mg and paracetamol 500 mg oral tablet |
Has precise active ingredient |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Codeine phosphate 30 mg and paracetamol 500 mg effervescent oral tablet |
Has precise active ingredient |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Codeine phosphate 30 mg and paracetamol 500 mg effervescent oral tablet |
Has basis of strength substance (attribute) |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Codeine phosphate 30 mg and paracetamol 500 mg oral capsule |
Has precise active ingredient |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Codeine phosphate 30 mg and paracetamol 500 mg oral capsule |
Has basis of strength substance (attribute) |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely dihydrocodeine tartrate 20 milligram and paracetamol 500 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely domperidone (as domperidone maleate) 10 milligram and paracetamol 500 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |